The EVES motif mediates both intermolecular and intramolecular regulation of c-Myb

Genes and Development

Volumn 10, Issue 15, 1996, Pages 1858-1869

  Dash, Ajeeta B ^a   Orrico, Frank C ^a   Ness, Scott A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

cofactors; negative regulation; oncoproteins; protein interactions; Transcription

Indexed keywords

ONCOPROTEIN; TRANSCRIPTION FACTOR;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONFORMATIONAL TRANSITION; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; NONHUMAN; ONCOGENE C MYB; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION;

VERTEBRATA;

EID: 0029786902     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.10.15.1858     Document Type: Article

References (75)

1. Altschul, S.F., W. Gish, W. Miller, E.W. Myers, and D.J. Lipman. 1990. Basic local alignment search tool. J. Mol. Biol. 215: 403-410.
2. Amaravadi, L. and M.W. King. 1994. Characterization and expression of the Xenopus c-Myb homolog. Oncogens 9: 971-974.
3. Aziz, N., J. Wu, J.W. Dubendorff, J.S. Lipsick, T.W. Sturgill, and T.P. Bender. 1993. c-Myb and v-Myb are differentially phosphorylated by p42mapk in vitro. Oncogene 8: 2259-2265.
4. Aziz, N., M.R. Miglarese, R.C. Hendrickson, J. Shabanowitz, T.W. Sturgill, D.F. Hunt, and T.P. Bender. 1995. Modulation of c-Myb-induced transcription activation by a phosphorylation site near the negative regulatory domain. Proc. Natl. Acad. Sci. 92: 6429-6433.
5. Bies, J., R. Mukhopadhyaya, J. Pierce, and L. Wolff. 1995. Only late, nonmitotic stages of granulocyte differentiation in 32Dcl3 cells are blocked by ectopic expression of murine c-myb and its truncated forms. Cell Growth Differ. 6: 59-68.
6. Bishop, J.M. 1991. Molecular themes in oncogenesis. Cell 64: 35-248.
7. Bortner, D.M. and M.C. Ostrowski. 1991. Analysis of the v-myb structural components important for transactivation of gene expression. Nucleic Acids Res. 19: 1533-1539.
8. Brent, R. and M. Ptashne. 1985. A eukaryotic transcriptional activator bearing the DNA specificity of a prokaryotic represser. Cell 43: 729-736.
9. Burk, O., S. Mink, M. Ringwald, and K.-H. Klempnauer. 1993. Synergistic activation of the chicken mim-1 gene by v-myb and C/EBP transcription factors. EMBO J. 12: 2027-2038.
10. Chen, R.-H. and J.S. Lipsick. 1993. Differential Transcriptional Activation by v-Myb and c-Myb in animal cells and Saccharomyces cervisiae. Mol. Cell. Biol. 13: 4423-4431.
11. Clarke, M.F., J.F. Kukowska-Latallo, E. Westin, M. Smith, and E.V. Prochownik. 1988. Constitutive expression of a c-myb cDNA blocks friend murine erythroleukemia cell differentiation. Mol. Cell. Biol. 8:1884-892.
12. Dai, P., H. Akimaru, Y. Tanaka, D.-X. Hou, T. Yasukawa, C. Kanei-Ishii, T. Takahashi, and S. Ishii. 1996. CBP as a transcriptional coactivator of c-Myb. Genes & Dev. 10: 528-540.
13. Dini, P.W. and J.S. Lipsick. 1993. Oncogenic truncation of the first repeat of c-Myb decreases DNA binding in vitro and in vivo. Mol. Cell. Biol. 13: 7334-7348.
14. Dini, P.W., J.T. Eltman, and J.S. Lipsick. 1995. Mutations in the DNA-binding and transcriptional activation domains of v-Myb cooperate in transformation. J. Virol. 69: 2515-2524.
15. Dubendorff, J.W., L.J. Whittaker, J.T. Eltman, and J.S. Lipsick. 1992. Carboxy-terminal elements of c-Myb negatively regulate transcriptional activation in cis and in trans. Genes & Dev. 6: 2524-2535.
16. Engelke, U., L. Whittaker, and J.S. Lipsick. 1995. Weak transcriptional activation is sufficient for transformation by v-Myb. Virology 208: 467-477.
17. Estojak, J., R. Brent, and E.A. Golemis. 1995. Correlation of two-hybrid affinity data with in vitro measurements. Mol. Cell. Biol. 15: 5820-5829.
18. Favier, D. and T.J. Gonda. 1994. Detection of proteins that bind to the leucine zipper motif of c-Myb. Oncogene 9: 305-311.
19. Ferrao, P., E.M. Macmillan, L.K. Ashman, and T.J. Gonda. 1995. Enforced expression of full length c-Myb leads to density-dependent transformation of murine haemopoietic cells. Oncogene 11: 1631-1638.
20. Fields, S. and O. Song. 1989. A novel genetic system to detect protein-protein interactions. Nature 340: 245-246.
21. Frampton, J., A. Leutz, T. Gibson, and T. Graf. 1989. DNA binding domain ancestry. Nature 342: 134.
22. Frampton, J., T. Kouzarides, G. Doderlein, T. Graf, and K. Weston. 1993. Influence of the v-Myb transactivation domain on the oncoprotein's transformation specificity. EMBO J. 12: 1333-1341.
23. Furuta, Y., S. Aizawa, Y. Suda, Y. Ikawa, H. Nakasgoshi, Y. Nishina, and S. Ishii. 1993. Degeneration of skeletal and cardiac muscles in c-myb transgenic mice. Transgen. Res. 2: 199-207.
24. v-myb. Oncogene 6: 265-273.
25. Gerondakis, S. and J.M. Bishop. 1986. Structure of the protein encoded by the chicken proto-oncogene c-myb. Mol. Cell. Biol. 6: 3677-3684.
26. Golay, J., A. Capucci, M. Arsura, M. Castellano, V. Rizzo, and M. Introna. 1991. Expression of c-myb and B-myb, but not A-myb, correlates with proliferation in human hematopoietic cells. Blood 77: 149-158.
27. Golemis, E.A. and R. Brent. 1992. Fused protein domains inhibit DNA binding by LexA. Mol Cell. Biol. 12: 3006-3014.
28. Gonda, T.J., C. Buckmaster, and R.G. Ramsay. 1989a. Activation of c-myb by carboxy-terminal truncation: Relationship to transformation of murine haemopoietic cells in vitro. EMBO J. 8: 1777-1783.
29. Gonda, T.J., R.G. Ramsay, and G.R. Johnson. 1989b. Murine myeloid cell lines derived by in vitro infection with recombinant c-myb retroviruses express myb from rearranged vector proviruses. EMBO J. 8: 1767-1175.
30. Grässer, F.A., T. Graf, and J. Lipsick. 1991. Protein truncation is required for the activation of the c-myb proto-oncogene. Mol. Cell. Biol. 11: 3987-3996.
31. Gu, B., R. Kuddus, and N.A. DeLuca. 1995. Repression of activator-mediated transcription by herpes simplex virus ICP4 via a mechanism involving interactions with the basal transcription factors TATA-binding protein and TFIIB. Mol. Cell. Biol. 15: 3618-3626.
32. Gyuris, J., E. Golemis, H. Chertkov, and R. Brent. 1993. Cdil, a human G1 and S phase protein phosphatase that associates with Cdk2. Cell 75: 791-803.
33. Howe, K.M., C.F.L. Reakes, and R.J. Watson. 1990. Characterization of the sequence-specific interaction of mouse c-myb protein with DNA. EMBO J. 9: 161-169.
34. Hu, Y., R.G. Ramsay, C. Kanei-Ishii, S. Ishii, and T.J. Gonda. 1991. Transformation by carboxyl-deleted Myb reflects increased transactivating capacity and disruption of a negative regulatory domain. Oncogene 6: 1549-1551.
35. Ibanez, C.E. and J.S. Lipsick. 1990. trans-Activation of gene expression by v-myb. Mol. Cell. Biol. 10: 2285-2293.
36. Introna, M., J. Golay, J. Frampton, T. Nakano, S.A. Ness, and T. Graf. 1990. Mutations in v-myb alter the differentiation of myelomonocytic cells transformed by the oncogene. Cell 63: 1287-1297.
37. Jonsen, M.D., J.M. Petersen, Q.-P. Xu, and B.J. Graves. 1996. Characterization of the cooperative function of inhibitory sequences in Ets-1. Mol Cell. Biol. 16: 2065-2073.
38. Kanei-Ishii, C., E.M. MacMillan, T. Nomura, A. Sarai, R.G. Ramsay, S. Aimoto, S. Ishii, and T.J. Gonda. 1992. Transactivation and transformation by Myb are negatively regulated by a leucine-zipper structure. Proc. Natl. Acad. Sci. 89: 3088-3092.
39. Katz, S., E. Kowenz-Leutz, C. Müller, K. Meese, S.A. Ness, and A. Leutz. 1993. The NF-M transcription factor is related to C/EBPβ and plays a role in signal transduction, differentiation and leukemogenesis of avian myelomonocytic cells. EMBO J. 12: 1321-1332.
40. Lane, T.N., C.E. Ibanez, A. Garcia, T. Graf, and J.S. Lipsick. 1990. Transformation by v-myb correlates with trans-activation of gene expression. Mol. Cell. Biol. 10: 2591-2598.
41. Lüscher, B., E. Christenson, D.W. Litchfield, E.G. Krebs, and R.N. Eisenman. 1990. Myb DNA binding inhibited by phos- phorylation at a site deleted during oncogenic activation. Nature 344: 517-522.
42. McClinton, D., J. Stafford, L. Brents, T.P. Bender, and W.M. Kuehl. 1990. Differentiation of mouse erythroleukemia cells is blocked by late up-regulation of a c-myb transgene. Mol. Cell. Biol. 10: 705-710.
43. Mizuguchi, G., C. Kanei-Ishii, T. Takahashi, T. Yasukawa, T. Nagase, M. Horikoshi, T. Yamamoto, and S. Ishii. 1995. c-Myb repression of c-erbB-2 transcription by direct binding to the c-erbB-2 promoter. J. Biol. Chem. 270: 9384-9389.
44. Mukhopadhyaya, R. and L. Wolff. 1992. New sites of proviral integration associated with murine promonocytic leukemias and evidence for alternate modes of c-myb activation. J. Virol. 66: 6035-6044.
45. Nason-Burchenal, K. and L. Wolff. 1993. Activation of c-myb is an early bone-marrow event in a murine model for acute promonocytic leukemia. Proc. Natl. Acad. Sci. 90: 1619-1623.
46. Natesan, S. and M. Gilman. 1995. YY1 facilitates the association of serum response factor with the c-fos serum response element. Mol. Cell. Biol. 15: 5975-5982.
47. Ness, S.A., A. Marknell, and T. Graf. 1989. The v-myb oncogene product binds to and activates the promyelocyte-specific mim-1 gene. Cell 59: 1115-1125.
48. Ness, S.A., E. Kowenz-Leutz, T. Casini, T. Graf, and A. Leutz. 1993. Myb and NF-M: Combinatorial activators of myeloid genes in heterologous cell types. Genes & Dev. 7: 749-759.
49. Ness, S.A. 1996. The Myb Oncoprotein: Regulating a regulator. Biochem. Biophys. Acta Rev. Cancer. (in press).
50. Nomura, N., M. Takahashi, M. Matsui, S. Ishii, T. Date, S. Shigemi, and R. Ishizaki. 1988. Isolation of human cDNA clones of myb-related genes, A-myb and B-myb. Nucleic Acids Res. 16: 11075-11089.
51. Nomura, T., N. Sakai, A. Sarai, T. Sudo, I.C. Kanei, R.G. Ramsay, D. Favier, T.J. Gonda, and S. Ishii. 1993. Negative auto-regulation of c-Myb activity by homodimer formation through the leucinc zipper. J. Biol. Chem. 268: 21914-21923.
52. Oelgeschläger, M., J. Krieg, J.M. Lüscher-Firzlaff, and B. Luscher. 1995. Casein kinase II phosphorylation site mutations in c-Myb affect DNA binding and transcriptional cooperativity with NF-M. Mol. Cell. Biol. 15: 5966-5974.
53. Oelgeschläger, M., R. Janknecht, J. Krieg, S. Schreck, and B. Lüscher. 1996. Interaction of the co-activator CBP with Myb proteins: Effects on the Myb-specific transcription and on the cooperativity with NF-M. EMBO J. 15: 2771-2780.
54. Ogata, K., H. Kanai, T. Inoue, A. Sekikawa, M. Sasaki, A. Nagadoi, A. Sarai, S. Ishii, and Y. Nishimura. 1993. Solution structures of Myb DNA-binding domain and its complex with DNA. Nucleic Acids Symp. Ser. 29: 201-202.
55. Ogata, K., S. Morikawa, H. Nakamura, A. Sekikawa, T. Inoue, H. Kanai, A. Sarai, S. Ishii, and Y. Nishimura. 1994. Solution structure of a specific DNA complex of the Myb DNA-binding domain with cooperative recognition helices. Cell 79: 639-648.
56. Parker, M.G. 1993. Steroid and related receptors. Curr. Opin. Cell Biol. 5: 499-504.
57. Petersen, J.M., J.J. Skalicky, L.W. Donaldson, L.P. McIntosh, T. Alber, and B.J. Graves. 1995. Modulation of transcription factor Ets-1 DNA binding: DNA-induced unfolding of an alpha helix. Science 269: 1866-1869.
58. Ramachandran, S., K. Hiratsuka, and N.H. Chua. 1994. Transcription factors in plant growth and development. Curr. Opin. Genet. Dev. 4: 642-646.
59. Ramsay, R.G., S. Ishii, and T.J. Gonda. 1991. Increase in specific DNA binding by carboxyl truncation suggests a mechanism for activation of Myb. Oncogene 6: 1815-1819.
60. Reddy, J.C., S. Hosono, and I.D. Licht. 1995. The transcriptional effect of WT1 is modulated by choice of expression vector. J. Biol. Chem. 270: 29976-29982.
61. Sakura, H., C. Kanai-Ishii, T. Nagase, H. Nakagoshi, T.J. Gonda, and S. Ishii. 1989. Delineation of three functional domains of the transcriptional activator encoded by the c-myb protooncogene. Proc. Natl. Acad. Sci. 86: 5758-5762.
62. Selvakumaran, M., D.A. Liebermann, and B. Hoffman-Liebermann. 1992. Deregulated c-myb disrupts interleukin-6 or leukemia inhibitory factor-induced myeloid differentiation prior to c-myc: Role in leukemogenesis. Mol. Cell. Biol. 12: 2493-2500.
63. Shen-Ong, G.L.C., M. Potter, J.F. Mushinski, S. Lavu, and E.P. Reddy. 1984. Activation of the c-myb locus by viral insertinal mutagenesis in plasmacytoid lymphosarcomas. Science 226: 1077-1080.
64. Shen-Ong, G.L.C., H.C. Morse III, M. Potter, and F. Mushinski. 1986. Two modes of c-myb activation in virus-induced mouse myeloid tumors. Mol. Cell. Biol. 6: 380-392.
65. Sleeman, J.P. 1993. Xenopus A-myb is expressed during early spermatogenesis. Oncogene 8: 1931-1941.
66. Smarda, J. and J.S. Lipsick. 1994. c-Myb prevents TPA-induced differentiation and cell death in v-Myb transformed monoblasts. Oncogene 9: 237-245.
67. Todokoro, K., R.J. Watson, H. Higo, H. Amanuma, S. Kuramochi, H. Yanagisawa, and Y. Ikawa. 1988. Down-regulation of c-myb gene expression is a prerequisite for erythropoietin-induccd erythroid differentiation. Proc. Natl. Acad. Sci. 85: 8900-8904.
68. Tong, X., R. Drapkin, R. Yalamanchili, G. Mosialos, and E. Kieff. 1995. The Epstein-Barr virus nuclear protein 2 acidic domain forms a complex with a novel cellular coactivator that can interact with TFIIE. Mol. Cell. Biol. 15: 4735-4744.
69. Trauth, K., B. Mutschler, N.A. Jenkins, D.J. Gilbert, N.G. Copeland, and K.H. Klempnauer. 1994. Mouse A-myb encodes a trans-activator and is expressed in mitotically active cells of the developing central nervous system, adult testis and B lymphocytes. EMBO J. 13: 5994-6005.
70. Treitel, M.A. and M. Carlson. 1995. Repression by SSN6-TUP1 is directed by MIG1, a repressor/activator protein. Proc. Natl. Acad. Sci. 92: 3132-3136.
71. Truss, M. and M. Beato. 1993. Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors. Endocrine Rev. 14: 459-479.
72. Vorbrueggen, G., F. Kalkbrenner, S. Guehmann, and K. Moelling. 1994. The carboxy terminus of human c-myb protein stimulates activated transcription in trans. Nucleic Acids Res. 22: 2466-2475.
73. Weston, K. and J.M. Bishop. 1989. Transcriptional activation by the v-myb oncogene and its cellular progenitor, c-myb. Cell 58: 85-93.
74. Yanagisawa, H., T. Nagasawa, S. Kuramochi, T. Abe, Y. Ikawa, and K. Todokoro. 1991. Constitutive expression of exogenous c-myb gene causes maturation block in monocyte-macrophage differentiation. Biochim. Biophys. Acta 1088: 380-384.
75. Zervos, A.S., J. Gyuris, and R. Brent. 1993. Mxil, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell 72: 223-232.